Otitis media is one of the most worldwide prevalent diseases that affects children. The socioeconomic costs may exceed 3.5 billion dollars a year in the United States alone in direct and indirect costs. If a vaccine can be developed that will decrease 1% of the illness this would be significant in this country and probably even more valuable in less developed countries.